172 related articles for article (PubMed ID: 31111759)
21. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
[TBL] [Abstract][Full Text] [Related]
22. [Effect of down-regulating mll-af9 gene expression on proliferation of acute monocytic leukemia cell line THP-1].
Li L; Zhang AH; Liu LB; Bi L; Wang L; Zhao YJ; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):254-7. PubMed ID: 18426643
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23).
Martino V; Tonelli R; Montemurro L; Franzoni M; Marino F; Fazzina R; Pession A
Oncol Rep; 2006 Jan; 15(1):207-11. PubMed ID: 16328057
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic significance of detecting MLL-AF9 fusion gene expression in patients with acute myeloid leukemia by real-time fluorescence quantitative PCR].
Huang S; Yang H; Gao L; Dou LP; Xu YY; Wang N; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1435-40. PubMed ID: 24370025
[TBL] [Abstract][Full Text] [Related]
25. Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL‑AF9 translocation.
Wang F; Li Z; Wang G; Tian X; Zhou J; Yu W; Fan Z; Dong L; Lu J; Xu J; Zhang W; Liang A
Mol Med Rep; 2020 Feb; 21(2):883-893. PubMed ID: 31789407
[TBL] [Abstract][Full Text] [Related]
26. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
[TBL] [Abstract][Full Text] [Related]
27. The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression.
Fleischmann KK; Pagel P; von Frowein J; Magg T; Roscher AA; Schmid I
J Exp Clin Cancer Res; 2016 Jan; 35():9. PubMed ID: 26762252
[TBL] [Abstract][Full Text] [Related]
28. Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation.
Heuts BMH; Arza-Apalategi S; Alkema SG; Tijchon E; Jussen L; Bergevoet SM; van der Reijden BA; Martens JHA
Cells; 2023 Apr; 12(8):. PubMed ID: 37190104
[TBL] [Abstract][Full Text] [Related]
29. Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.
Young K; Loberg MA; Eudy E; Schwartz LS; Mujica KD; Trowbridge JJ
Exp Hematol; 2020 Sep; 89():61-67.e3. PubMed ID: 32768438
[TBL] [Abstract][Full Text] [Related]
30. RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes.
Fleischmann KK; Pagel P; Schmid I; Roscher AA
Mol Cancer; 2014 Feb; 13():27. PubMed ID: 24517546
[TBL] [Abstract][Full Text] [Related]
31. The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
Wang H; Bei L; Shah CA; Huang W; Platanias LC; Eklund EA
Oncogene; 2018 May; 37(19):2532-2544. PubMed ID: 29459712
[TBL] [Abstract][Full Text] [Related]
32. Validation of an interphase fluorescence in situ hybridization approach for the detection of MLL gene rearrangements and of the MLL/AF9 fusion in acute myeloid leukemia.
Cavazzini F; Bardi A; Tammiso E; Ciccone M; Russo-Rossi A; Divona D; Lo Coco F; Hernandez JM; Wlodarska I; Hagemeijer A; Castoldi G; Cuneo A
Haematologica; 2006 Mar; 91(3):381-5. PubMed ID: 16503549
[TBL] [Abstract][Full Text] [Related]
33. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
[TBL] [Abstract][Full Text] [Related]
34. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.
Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Chen S; Zhang J; Li B
Biochem Biophys Res Commun; 2022 Mar; 596():36-42. PubMed ID: 35108652
[TBL] [Abstract][Full Text] [Related]
35. Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9.
Zhang LS; Kang X; Lu J; Zhang Y; Wu X; Wu G; Zheng J; Tuladhar R; Shi H; Wang Q; Morlock L; Yao H; Huang LJ; Maire P; Kim J; Williams N; Xu J; Chen C; Zhang CC; Lum L
EBioMedicine; 2019 Jan; 39():145-158. PubMed ID: 30528456
[TBL] [Abstract][Full Text] [Related]
36. RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.
Kim WI; Matise I; Diers MD; Largaespada DA
Blood; 2009 Jan; 113(5):1086-96. PubMed ID: 18952898
[TBL] [Abstract][Full Text] [Related]
37. Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias.
Burmeister T; Meyer C; Gröger D; Hofmann J; Marschalek R
Leuk Res; 2015 Feb; 39(2):242-7. PubMed ID: 25510485
[TBL] [Abstract][Full Text] [Related]
38. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
[TBL] [Abstract][Full Text] [Related]
39. [Effect of MLL-AF9 fusion gene silence of acute monocytic leukemia cell line THP-1 on cyclin-dependent kinase inhibitor p27 expression].
Li L; Liu LB; Wang L; Zou P
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):375-8. PubMed ID: 19031738
[TBL] [Abstract][Full Text] [Related]
40. ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia.
Wang Y; Skibbe JR; Hu C; Dong L; Ferchen K; Su R; Li C; Huang H; Weng H; Huang H; Qin X; Jin J; Chen J; Jiang X
Sci Rep; 2017 May; 7(1):1853. PubMed ID: 28500307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]